This article is part of the series "[Podcast] Adam Tanner on the Dark Market in Medical Data". Check out the rest:
In our writing about HIPAA and medical data, we’ve also covered a few of the gray areas of medical privacy, including wearables, Facebook, and hospital discharge records. I thought both Cindy and I knew all the loopholes. And then I talked to writer Adam Tanner about his new book Our Bodies, Our Data: How Companies Make Billions Selling Our Medical Records.
In the first part of my interview with Tanner, I learned how pharmacies sell our prescription drug transactions to medical data brokers, who then resell it to pharmaceutical companies and others. This is a billion dollar market that remains unknown to the public.
How can this be legal under HIPAA, and why doesn’t it require patient consent?
It turns out after the data record is anonymized, but with the doctor’s name still attached, it’s no longer yours! Listen in as we learn more from Tanner in this first podcast.